{"member_organisations": "", "identification_number": "486226117071-45", "fields_of_interest": "Humanitarian aid and civil protection, Competition, Consumers, Customs, Business and Industry, Taxation, Single market, Research and innovation, Public Health", "head_office_address": "EKC - Mosquito Way", "full_time_equivalent_fte": "0,5", "person_with_legal_responsibility": "Simon Thomas", "industry_forums": "", "grants": "", "inter_groups": "", "eu_initiatives": "Healthcare Policy  \nPharmaceutical Legislation \nPharmaceutical Industrial Policy \nCompetition \nIntellectual Property", "level_of_interest": "global", "organisation_name": "Eisai Europe Ltd", "belgium_office_post_code": "3000", "number_of_persons_involved": "2", "person_in_charge_of_eu_relations": "David Jefferys", "section": "II - In-house lobbyists and trade/business/professional associations", "source": "", "subsection": "Companies & groups", "belgium_office_phone": "(+32)016140490", "overall_budget_turnover_as_a_range": "", "belgium_office_address": "Brusselsestraat 190", "no_geo_reference": true, "persons_accredited_for_access_to_european_parliament_premises": "", "registration_date": "22/04/2015", "estimate_of_costs_absolute_amount": "", "website_address": "http://www.eisai.co.uk", "commission_expert_groups_and_other_similar_entities_european_commission": "NA", "head_office_post_box": "", "head_office_city": "Hatfield", "membership": "European Federation of Pharmaceutical Industries and Associations \nThe Association of the British Pharmaceutical Industry", "head_office_post_code": "AL10 9SN", "position": "Snr Vice President, Global Reg.Public Affairs", "financial_year_start_date": "01/04/2016", "head_office_country": "United Kingdom", "number_of_ep_accredited_persons": "", "relevant_communication": "", "financial_year_end_date": "01/03/2017", "estimate_of_costs_as_a_range": "25000-49999", "overall_budget_turnover_absolute_amount": "0", "legal_status": "Corporation", "procurement": "", "customers": "", "belgium_office_post_box": "", "goals__remit": "Around the world there are still many diseases for which no effective treatments exist and many patients who do not have adequate access to the medicines they need. As a global pharmaceutical company addressing these unmet medical needs, Eisai is committed to making contributions to better healthcare for patients and their families around the world through its business activities.", "belgium_office_city": "Leuven", "head_office_phone": "(+44)845 676 1400"}